Peripheral Arterial Disease
📧 Sign up to get email alerts when something new happens for Peripheral Arterial Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-12-31FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for Cilostazol (generic Cilostazol). This action typically involves u…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Granulocyte-Macrophage Stimulating Factor in the Treatment of Peripheral Arterial Disease [Phase 2]
A Phase 2 trial evaluated Granulocyte-Macrophage Stimulating Factor (GM-CSF) for the treatment of Peripheral Arterial Disease; results from …
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Effects of Dietary Flaxseed on Symptoms of Cardiovascular Disease in Patients With Peripheral Arterial Disease [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluated the effect of dietary flaxseed on cardiovascular symptoms in patients with peripheral arterial disease;…
-
CLINICAL_TRIALS trial_result · 2014-12-11Clinical Trial Update: Autologous Bone Marrow Mononuclear Cell Implantation for Moderate to Severe Peripheral Arterial Disease [NA]
This clinical trial update reports on autologous bone marrow mononuclear cell implantation as a treatment for moderate to severe peripheral …
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: Validation of the Korean Version of the Walking Impairment Questionnaire in Patients With Peripheral Arterial Disease
This clinical trial update reports the validation of the Korean version of the Walking Impairment Questionnaire in patients with peripheral …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-09-23FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Cilostazol from Teva Pharmaceuticals USA, Inc., updating the labeling for the drug. This constit…
-
CLINICAL_TRIALS research · 2014-09-19Clinical Trial Update: Heart Rate and Cardiovascular Diseases Prognosis in People With Stable Coronary Artery Disease
Clinical trial update examining the relationship between heart rate and prognosis across multiple cardiovascular conditions in people with s…
-
FDA approval · 2014-09-15FDA Approved: CLOPIDOGREL BISULFATE — Original Application (RADHA PHARMACEUTICALS, INC.)
FDA approved the original ANDA for clopidogrel bisulfate, a generic antiplatelet agent, expanding access to a therapy that reduces vascular …
-
CLINICAL_TRIALS trial_result · 2014-08-26Clinical Trial Update: OMEGA-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Peripheral Arterial Disease [Phase 3]
A Phase 3 clinical trial evaluating omega-3 polyunsaturated fatty acids (N3-Pufa) in Peripheral Arterial Disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-25Clinical Trial Update: Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study) [Phase 4]
Phase 4 clinical trial evaluating the effectiveness of intensive lipid modification therapy in preventing progression of peripheral arterial…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Investigation of Safety, Pharmacokinetics and Pharmacodynamics of Different Doses of BIWH 3 in Patients With Chronic Critical Limb Ischaemia [Phase 1]
This Phase 1 study assesses safety, pharmacokinetics and pharmacodynamics of multiple doses of BIWH 3 in patients with chronic critical limb…
-
CLINICAL_TRIALS withdrawal · 2014-08-15Clinical Trial Update: Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease [Phase 4]
Phase 4 trial evaluating ranolazine versus placebo in patients with peripheral arterial disease and angina has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Investigating a Model for Acute Ischemic Pain in Humans [NA]
This document reports the completion of a clinical trial investigating a model for acute ischemic pain in humans. The study was conducted in…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Clinical Pilot-Study of ProEndoTecc Vascular Grafts as Superficial Femoral Artery Bypass / Interponate [NA]
A terminated pilot clinical trial evaluated ProEndoTecc vascular grafts for superficial femoral artery bypass (Interponate) in peripheral ar…
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Study of the SilverHawk™ /TurboHawk™ Plaque Excision Systems Used With SpiderFX to Treat Calcified Peripheral Arterial Disease (DEFINITIVE Ca++) [Phase 2, Phase 3]
This clinical trial update reports the completion and posting of results for a Phase 2/3 study evaluating the SilverHawk/TurboHawk plaque ex…
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC [Phase 2]
Phase IIa trial evaluating safety, pharmacokinetics, and tolerability of sodium nitrite in patients with peripheral arterial disease; result…
-
CLINICAL_TRIALS research · 2014-07-01Clinical Trial Update: Imaging and Interventional Study for Erectile Dysfunction and Lower Urinary Tract Symptoms [NA]
An imaging and interventional clinical trial for erectile dysfunction, lower urinary tract symptoms, and peripheral arterial disease is bein…
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737) [Phase 3]
Phase 3 trial results update for vorapaxar (TRA 2°P-TIMI 50) in patients with atherosclerosis assessing prevention of heart attack and strok…
-
CLINICAL_TRIALS research · 2014-04-24Clinical Trial Update: The Use of Cardiovascular Biomarkers in Abdominal Aortic Surgery
This clinical trial update reviews the use of cardiovascular biomarkers in abdominal aortic surgery and their potential relevance to outcome…
-
CLINICAL_TRIALS trial_result · 2014-04-24Clinical Trial Update: Evaluation of Efficacy of the EPIC™ Self-Expanding Nitinol Vascular Stent [NA]
A completed clinical trial evaluating the efficacy of the EPIC Self-Expanding Nitinol Vascular Stent for peripheral arterial disease and sup…
-
CLINICAL_TRIALS trial_result · 2014-04-16Clinical Trial Update: Zilver PTX Drug-Eluting Peripheral Stent Study [NA]
This clinical trial (NCT01348425) evaluating the Zilver PTX paclitaxel-eluting peripheral stent for Peripheral Arterial Disease has complete…
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Reducing Risk Factors in Peripheral Arterial Disease [NA]
Northwestern University completed a clinical trial focused on reducing risk factors in peripheral arterial disease.
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: Community-Based Detection and Treatment of Peripheral Arterial Disease in Hispanics. [NA]
A completed community-based trial evaluated detection and treatment of peripheral arterial disease in Hispanic participants, with results po…
-
CLINICAL_TRIALS withdrawal · 2014-03-20Clinical Trial Update: Prolongation of the Interval Between Prothrombin Time Tests in Stable Patients II [Phase 3]
A Phase 3 trial evaluating prolongation of the interval between prothrombin time tests in stable patients with atrial fibrillation and valvu…
-
FDA approval · 2014-03-04FDA Approved: CLOPIDOGREL — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s original generic application for clopidogrel bisulfate (clopidogrel).